Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

PSEUDOEPHEDRINE HYDROCHLORIDE AND GUAIFE

Awarded
SPE2D226F3012Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Delivery order SPE2D2-26-F-3012, issued on July 14, 2026, by the Defense Logistics Agency Troop Support Medical Supply Chain, authorizes DMS Pharmaceutical Group Inc to provide Pseudoephedrine Hydrochloride and Guaifenesin. This small business award, which also qualifies as a women-owned and small disadvantaged business, is placed under base contract SPE2DX-25-D-9822. The order consists of a single line item for six units of the pharmaceutical product (NSN 6505015598774) at a unit price of $7.00, resulting in a total contract value of $42.00. The items are to be delivered FOB Destination to the USNS Loyal (T-AGOS 22) at FPO AP 96671 by July 14, 2026. Inspection and acceptance will be conducted by the government at the destination to ensure the product conforms to contract requirements. All shipments must be marked with the NSN, CAGE code 1UNB0, and shipment identifier N218686195S606. Payment is administered by the Defense Finance and Accounting Service in Columbus, Ohio, with Lisa Quinn serving as the contracting officer and Jayne Do providing administrative support.

General Info

DMS Pharmaceutical Group provides Pseudoephedrine and Guaifenesin to DLA for $42.00 by July 2026.

Contract Value

$42

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

2

SPE2D2-26-F-3012 Delivery Order

PDF, High priority: read this firsttask-order-award
High

SPE2D226F3012.pdf

PDF, Low priorityother
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2D226F3012 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $42.00 Award Date: 07-14-2026 Delivery order under: SPE2DX25D9822 Line items: - PSEUDOEPHEDRINE HYDROCHLORIDE AND GUAIFE (NSN/Part 6505015598774, PR 7017500908)

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
International
Pralidoxime
Solicitation # W6369-26-A033/B
The Department of National Defence, through the Strategic Medical Countermeasures Program, is soliciting offers for the procurement of Pralidoxime Chloride or Pralidoxime Methyl Sulfate to treat Canadian Armed Forces members exposed to chemical warfare agents. The contract includes an initial requirement for 450 treatment courses to be delivered by March 31, 2027, with optional requirements for an additional 600 doses to be delivered between April 1, 2027, and March 31, 2031. A treatment course is defined as 1 gram per day for seven days. The award will be granted to the compliant offer with the lowest evaluated price, based on Delivered at Place terms for the Central Medical Equipment Depot in Petawawa, Ontario. Technical requirements mandate that the product be manufactured according to current Good Manufacturing Practices and hold a Health Canada issued Notice of Compliance or appropriate authorization. The medication must have a minimum shelf-life of 36 months from the date of manufacture and be delivered in a temperature-controlled environment, specifically maintained between 2 to 8 degrees Celsius, with continuous electronic monitoring and a Certificate of Conformity provided upon delivery. All packaging and drug inserts must be available in English or French. There are no security requirements associated with this procurement, and the solicitation is open to Canadian suppliers and those of applicable trading partners.
Department of National Defence

POSTED

1 day ago

DEADLINE

in 20 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS